Assembly Biosciences Profit Margin vs. EBITDA
| ASMB Stock | USD 15.04 0.32 2.17% |
Assembly Biosciences Net Profit Margin |
|
For Assembly Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Assembly Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Assembly Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Assembly Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Assembly Biosciences over time as well as its relative position and ranking within its peers.
Assembly |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.89) | Revenue Per Share 4.125 | Quarterly Revenue Growth (1.00) | Return On Assets (0.35) | Return On Equity (1.02) |
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Assembly Biosciences EBITDA vs. Profit Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Assembly Biosciences's current stock value. Our valuation model uses many indicators to compare Assembly Biosciences value to that of its competitors to determine the firm's financial worth. Assembly Biosciences is rated second in profit margin category among its peers. It is rated below average in ebitda category among its peers . At present, Assembly Biosciences' Net Loss is projected to drop based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Assembly Biosciences' earnings, one of the primary drivers of an investment's value.Assembly EBITDA vs. Profit Margin
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Assembly Biosciences |
| = | (2.12) % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Assembly Biosciences |
| = | (64.2 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Assembly EBITDA Comparison
Assembly Biosciences is currently under evaluation in ebitda category among its peers.
Assembly Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Assembly Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Assembly Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Assembly Biosciences' change in net profit over the period of time. It can combine multiple indicators of Assembly Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -81 K | -85 K | |
| Operating Income | -64.6 M | -67.9 M | |
| Net Loss | -61.2 M | -64.3 M | |
| Income Tax Expense | 33 K | 34.6 K | |
| Income Before Tax | -61.2 M | -64.3 M | |
| Total Other Income Expense Net | 3.5 M | 3.6 M | |
| Net Loss | -72.7 M | -76.3 M | |
| Non Operating Income Net Other | 1.2 M | 1.3 M | |
| Net Loss | -83.8 M | -88 M | |
| Net Interest Income | 2.4 M | 1.6 M | |
| Interest Income | 2.4 M | 1.6 M | |
| Change To Netincome | 11.6 M | 15.8 M | |
| Net Loss | (13.38) | (14.05) | |
| Income Quality | (0.37) | (0.35) | |
| Net Income Per E B T | 1.00 | 0.62 |
Assembly Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Assembly Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Assembly Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Assembly Biosciences' important profitability drivers and their relationship over time.
Use Assembly Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Assembly Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assembly Biosciences will appreciate offsetting losses from the drop in the long position's value.Assembly Biosciences Pair Trading
Assembly Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Assembly Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Assembly Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Assembly Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Assembly Biosciences to buy it.
The correlation of Assembly Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Assembly Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Assembly Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Assembly Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Assembly Biosciences position
In addition to having Assembly Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sector ETFs Thematic Idea Now
Sector ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sector ETFs theme has 440 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sector ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
To fully project Assembly Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Assembly Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Assembly Biosciences' income statement, its balance sheet, and the statement of cash flows.